Open Beta
TREN
MetriLume
TREN

US marketsELTP

SEC-sourced researchBeta

ELTP

ELITE PHARMACEUTICALS INC /NV/

Company comparison ↗

Data passport

CIK
0001053369
Exchange
OTC
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 10, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: March 2025: 84,043,929.0000 USD; March 2026: 148,870,119.0000 USD148.9M USD0 USD0March 2025March 2026
ELTP · Exact amounts and source periods · USD
Period endRevenueFiling date
March 202584,043,929.0000Jun 29, 2026
March 2026148,870,119.0000Jun 29, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
March 2026148,870,119.000044,872,686.000023,748,094.0000138,289,840.000039,406,865.0000Jun 29, 2026
March 202584,043,929.0000-4,314,659.00007,455,639.000096,387,477.000042,872,448.0000Jun 29, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$148.87MMarch 2026Jun 29, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$84.04MMarch 2025Jun 29, 202610-K
Net incomeNetIncomeLoss$44.87MMarch 2026Jun 29, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$23.75MMarch 2026Jun 29, 202610-K
Total assetsAssets$138.29MMarch 2026Jun 29, 202610-K
Total liabilitiesLiabilities$39.41MMarch 2026Jun 29, 202610-K

New filings

Explore methodology ↗